key: cord-0752675-deenkt6k authors: Yannic, Kunz; Wolfgang, Horninger; Germar-Michael, Pinggera title: Cave canem: urine is not urine in corona times date: 2020-08-03 journal: Future Oncol DOI: 10.2217/fon-2020-0689 sha: 06ee7ff407afa3b48bb41bc83b04e7dc833e2a2b doc_id: 752675 cord_uid: deenkt6k nan proximal tubular units and, to a lesser extent, the podocytes, but not in the glomerular, endothelial and mesangial cells. Moreover, the net surface expression of this ACE2 receptor has been shown to be altered in several clinical conditions, such as diabetes, arterial hypertension and heart disease [17] . Once the kidneys' morphological structures are damaged after SARS-CoV-2 infection, this might lead to acute kidney failure (AKI) [18, 19] . By Kaplan-Meier analysis, it was demonstrated that renal failure had a greater risk for in-hospital mortality, and finally, Cox regression models confirmed AKI as an independent risk factor for predicting in-hospital patients' mortality [10] . Therefore, it is conceivable that particles or complete SARS-CoV-2 virus might be detectable in the urine. It is possible that urinary excretion is dependent on the infection cycle or severity of tissue damage. Thus, to assess and figure out any renal damage by SARS-CoV-2, a systematic, prospective investigation with an autopsy registry was initiated to facilitate COVID-19 research [20] . As stated in our recent review [21] , three work groups isolated viral nucleic acid in the urine in various patients. This seems to be especially delicate since urine specimens remain positive even after a negative pharyngeal swab [22] [23] [24] . Still, more recent studies underline these findings. The Chinese work group of Ling et al. recently published a positive urine detection rate of 6.9% (4/58) [22] . This is supported by Zhang et al., who observed a detection rate of 8.7% (2/23) [25] in one collective and 1.5% (1/67) in another [26] . Wang et al. investigated 48 patients with confirmed COVID-19 and proofed SARS-CoV-2 RNA in 6.25% (3/48) of cases [23] . Similarly, Peng et al. showed SARS-CoV-2 in one patient from a small positively tested collective, 11.1% (1/9) [24] . More recently, the Korean group by Kim et al. tested two patients positive in the urine in a bigger collective, 0.8% (2/247) [27] and by Sun et al. in a well-characterized patient case [28] . According to these six studies, roughly 3% of the tested patients showed positive results in the urine (13/452), posing a possible hazard for their caretakers. Therefore, disease transmission risk during urologic interventions by urine should not be completely neglected; especially urologists should not be careless in this field. Nevertheless, the transmission pathways of SARS-CoV-2 are not yet completely understood, the viral load might be only of transient character and the actual infection rate by SARS-CoV-2 via positive urine specimens remains to be investigated. In addition, the study designs are very different. Especially sample time differs vastly between the protocols, possibly explaining the different outcomes. Considering that SARS-CoV-2 could sometimes not be detected within the same patient at different measurements, there is implication for potentially increased unknown numbers. On the contrary, we have to appreciate that there are several other studies not in line with the preceding findings. [34] .) Summarizing the mentioned data, it appears that these inherent study conflicts are explained by low sample analysis, unclear methodological quality of the studies, temperature and needed time of sample assessment, as well as time of sample investigation after disease onset. Irrespective of these diverging results on urine contamination, it should be at least recognized that several study groups found SARS-CoV-2 viral load in the urine. Furthermore, SARS-CoV-2 was even detected in wastewater by RT-PCR [35] [36] [37] . In addition, we wish to present a Chinese study with 15% positive findings of SARS-CoV-2 in semen analysis as well, as this might concern urologists in their daily routine [38, 39] . The safety of healthcare workers should be the primary concern and guideline to the treatment of COVID-19 patients. This is even more relevant in tandem with the newly published data on COVID-19 cases among healthcare workers [40] . We would like to emphasize that we strongly agree with the original authors in this instance. Therefore, in accordance with the positive findings of SARS-CoV-2 in the urine mentioned previously, we recommend, in unison with the European Association of Urology guidelines on COVID-19 [41] , special precautions even in endourology. The reassurance given by the original authors (Condon et al. [1] ) at least for endourologists cannot be approved by us. Therefore, personal protective equipdment with FFP-2 masks and face shields should be utilized. Furthermore, closed suction devices for urine drainage seem reasonable. These recommendations are also in accordance with the newly published guidelines by strengthening all measures for protection of occupational health, safety and security of health workers by the WHO (WHO/2019-nCoV/HCF operations/2020.1) or others. However, especially oncologic endourologic interventions should not be postponed indefinitely in SARS-CoV-2 patients, when in fact net virus transmission by infected urine has not been described to date. Implications of COVID-19 on urological laparoscopic surgery Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor Coronaviruses: an overview of their replication and pathogenesis Detection of SARS coronavirus in patients with suspected SARS Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study Quantitative detection of SARS-CoV RNA in excreta and oropharyngeal washing fluid from convalescence patients with severe acute respiratory syndrome A new coronavirus associated with human respiratory disease in China A pneumonia outbreak associated with a new coronavirus of probable bat origin Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein Angiotensin converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2 The hallmarks of COVID-19 disease Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 Endothelial cell infection and endotheliitis in COVID-19 Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China Angiotensin converting enzyme: a review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade Coronavirus-nephropathy; renal involvement in COVID-19 Autopsy registry can facilitate COVID-19 research Are urologists in trouble by SARS-CoV-2? Reflexions and recommendations for specific interventions Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China novel coronavirus can be detected in urine, blood, anal swabs and oropharyngeal swabs samples. medRxiv Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province Detection and isolation of SARS-CoV-2 in serum, urine, and stool specimens of COVID-19 patients from the Republic of Korea Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient First 12 patients with coronavirus disease 2019 (COVID-19) in the United States Virological assessment of hospitalized patients with COVID-2019 A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau Clinical and virological data of the first cases of COVID-19 in Europe: a case series Wastewater-based epidemiology: global collaborative to maximize contributions in the fight against COVID-19 First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: a proof of concept for the wastewater surveillance of COVID-19 in the community First detection of SARS-CoV-2 in untreated wastewaters in Italy Clinical characteristics and results of semen tests among men with coronavirus disease 2019 Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab Comparing dynamics and determinants of SARS-CoV-2 transmissions among health care workers of adult and pediatric settings in central Paris An organisation-wide collaborative effort to adapt the EAU guidelines recommendations to the COVID-19 era